Clinical significance of cardiovascular dysmetabolic syndrome

Area of Science:

• Cardiology
• Endocrinology
• Metabolic Disorders

Background:

• Diabetes mellitus, primarily a metabolic disorder, increasingly recognized as a vascular disorder.
• Cardiovascular complications are the leading cause of mortality and morbidity in diabetic patients.
• Atherosclerosis often progresses by the time of diabetes diagnosis, linked to dyslipidemia, hypertension, hyperglycemia, hyperinsulinemia, and endothelial dysfunction.

Purpose of the Study:

• To highlight the vascular nature of diabetes mellitus.
• To emphasize the importance of early identification of individuals at risk for cardiovascular complications.
• To discuss therapeutic strategies for cardiovascular dysmetabolic syndrome and diabetes mellitus.

Main Methods:

• Review of recent reports and evolving knowledge on metabolic, hormonal, and hemodynamic abnormalities in diabetes.
• Focus on insulin resistance as a preceding factor in type II diabetes.
• Attention to criteria for cardiovascular dysmetabolic syndrome for early risk identification.

Main Results:

• Insulin resistance, central to type II diabetes, often precedes clinical diagnosis by 5-6 years.
• Cardiovascular dysmetabolic syndrome criteria aid in early risk stratification.
• Nonpharmacologic and pharmacologic therapies can improve insulin sensitivity and related abnormalities.

Conclusions:

• Diabetes mellitus poses a significant vascular risk, necessitating early detection of associated conditions.
• Managing cardiovascular dysmetabolic syndrome is key to mitigating diabetes-related cardiovascular disease.
• Timely therapeutic interventions are essential to combat the growing epidemic of diabetes-related cardiovascular disease.